Partially deglycosylated equine LH preferentially activates β-arrestin-dependent signaling at the follicle-stimulating hormone receptor

Molecular Endocrinology

Volumn 24, Issue 3, 2010, Pages 561-573

  Wehbi, Vanessa ^a,b,c,d   Tranchant, Thibaud ^a,b,c,d   Durand, Guillaume ^a,b,c,d   Musnier, Astrid ^a,b,c,d   Decourtye, Jérémy ^a,b,c,d   Piketty, Vincent ^a,b,c,d   Butnev, Vladimir Y ^e   Bousfield, George R ^e   Crépieux, Pascale ^a,b,c,d   Maurel, Marie Christine ^a,b,c,d   Reiter, Eric ^a,b,c,d  

^a Unité Mixte de Recherche   (France)

^b CNRS   (France)

^c Haras Nationaux   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e WICHITA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; BETA ARRESTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FOLLITROPIN RECEPTOR; LUTEINIZING HORMONE; LUTEINIZING HORMONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN S6;

ARTICLE; BIOACCUMULATION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; BLOTTING, WESTERN; CATTLE; CELL LINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; FEMALE; HORSES; HUMANS; IMMUNOPRECIPITATION; LUTEINIZING HORMONE; MICE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, FSH; RIBOSOMAL PROTEIN S6; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SWINE;

EQUIDAE;

EID: 77249123446     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0347     Document Type: Article

References (81)

1. Troispoux C, Guillou F, Elalouf JM, Firsov D, Iacovelli L, De Blasi A, Combarnous Y, Reiter E 1999 Involvement ofGprotein-coupled receptor kinases and arrestins in desensitization to follicle-stimulating hormone action. Mol Endocrinol 13:1599-1614
2. Lazari MF, Liu X, Nakamura K, Benovic JL, AscoliM1999 Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation and internalization of the follitropin receptor. Mol Endocrinol 13:866-878
3. Marion S, Robert F, Crepieux P, Martinat N, Troispoux C, Guillou F, Reiter E 2002 G protein-coupled receptor kinases and β-arrestins are relocalized and attenuate cyclic 3′,5′-adenosine monophosphate response to follicle-stimulating hormone in rat primary Sertoli cells. Biol Reprod 66:70-76
4. Tohgo A, Pierce KL, Choy EW, Lefkowitz RJ, Luttrell LM 2002 β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J Biol Chem 277:9429-9436
5. Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ 2005 Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci USA 102:1448-1453
6. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, Lefkowitz RJ 2006 Distinct β-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281:10856-10864
7. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ 2006 β-Arrestin-dependent, G protein-independent ERK1/2 activation by the β2 adrenergic receptor. J Biol Chem 281:1261-1273
8. Kara E, Crépieux P, Gauthier C, Martinat N, Piketty V, Guillou F, Reiter E 2006Aphosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for β-arrestin-mediated ERK activation. Mol Endocrinol 20:3014-3026
9. Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, Lefkowitz RJ 2005 β-Arrestin 1 and Gαq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 280:8041-8050
10. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG 2005 An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122: 261-273
11. Hunton DL, Barnes WG, Kim J, Ren XR, Violin JD, Reiter E, Milligan G, Patel DD, Lefkowitz RJ 2005 β-Arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Mol Pharmacol 67:1229-1236
12. Lefkowitz RJ, Shenoy SK 2005 Transduction of receptor signals by β-arrestins. Science 308:512-517
13. Reiter E, Lefkowitz RJ 2006 GRKs and β-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17: 159-165
14. Witherow DS, Garrison TR, Miller WE, Lefkowitz RJ 2004 β-Arrestin inhibits NF-κB activity by means of its interaction with the NF-κB inhibitor IκBα. Proc Natl Acad Sci USA 101:8603-8607
15. Azzi M, Charest PG, Angers S, Rousseau G, Kohout T, Bouvier M, Piñeyro G 2003 β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G proteincoupled receptors. Proc Natl Acad Sci USA 100:11406-11411
16. Wei H, Ahn S, Shenoy SK, Karnik SS, Hunyady L, Luttrell LM, Lefkowitz RJ 2003 Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signalregulated kinases 1 and 2. Proc Natl Acad Sci USA 100:10782-10787
17. Drake MT, Violin JD, Whalen EJ, Wisler JW, Shenoy SK, Lefkowitz RJ 2008 β-Arrestin-biased agonism at the β2-adrenergic receptor. J Biol Chem 283:5669-5676
18. Wisler JW, DeWire SM, Whalen EJ, Violin JD, Drake MT, Ahn S, Shenoy SK, Lefkowitz RJ 2007 A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling. Proc Natl Acad Sci USA 104:16657-166562
19. Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, Caron MG 2008 Antagonism of dopamine D2 receptor/β-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci USA 105:13656-13661
20. Violin JD, Lefkowitz RJ 2007 β-Arrestin-biased ligands at seventransmembrane receptors. Trends Pharmacol Sci 28:416-422
21. Kenakin T 2007 Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 28:407-415
22. Galandrin S, Oligny-Longpré G, Bouvier M 2007 The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28:423-430
23. Ulloa-Aguirre A, Timossi C, Barrios-de-Tomasi J, Maldonado A, Nayudu P 2003 Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models. Biol Reprod 69:379-389
24. Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G 1971 The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 246:1461-1467
25. Blum WF, Gupta D 1985 Heterogeneity of rat FSH by chromatofocusing: studies on serum FSH, hormone released in vitro and metabolic clearance rates of its various forms. J Endocrinol 105:29-37
26. Wide L, Hobson B 1986 Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary. Acta Endocrinol (Copenh) 113:17-22
27. Dahl KD, Stone MP 1992 FSH isoforms, radioimmunoassays, bioassays, and their significance. J Androl 13:11-22
28. Sairam MR, Bhargavi GN 1985 A role for glycosylation of the α-subunit in transduction of biological signal in glycoprotein hormones. Science 229:65-67
29. Padmanabhan V, Sairam MR, Hassing JM, Brown MB, Ridings JW, Beitins IZ 1991 Follicle-stimulating hormone signal transduction: role of carbohydrate in aromatase induction in immature rat Sertoli cells. Mol Cell Endocrinol 79:119-128
30. Stanton PG, Robertson DM, Burgon PG, Schmauk-White B, Hearn MT 1992 Isolation and physicochemical characterization of human follicle-stimulating hormone isoforms. Endocrinology 130:2820-2832
31. Burgon PG, Robertson DM, Stanton PG, Hearn MT 1993 Immunological activities of highly purified isoforms of human FSH correlate with in vitro bioactivities. J Endocrinol 139:511-518
32. Matzuk MM, Keene JL, Boime I 1989 Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction. J Biol Chem 264:2409-2414
33. Bishop LA, Robertson DM, Cahir N, Schofield PR 1994 Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction. Mol Endocrinol 8:722-731
34. Flack MR, Froehlich J, Bennet AP, Anasti J, Nisula BC 1994 Sitedirected mutagenesis defines the individual roles of the glycosylation sites on follicle-stimulating hormone. J Biol Chem 269:14015-14020
35. Heikoop JC, van den Boogaart P, de Leeuw R, Rose UM, Mulders JW, Grootenhuis PD 1998 Partially deglycosylated human choriogonadotropin, stabilized by intersubunit disulfide bonds, shows full bioactivity. Eur J Biochem 253:354-356
36. 56-deglycosylated equine LHαcombine to produce a potent FSH antagonist. J Endocrinol 172:545-555
37. Liu WK, Young JD, Ward DN1984 Deglycosylated ovine lutropin: preparation and characterization by in vitro binding and steroidogenesis. Mol Cell Endocrinol 37:29-39
38. Chen HC, Shimohigashi Y, Dufau ML, Catt KJ 1982 Characterization and biological properties of chemically deglycosylated human chorionic gonadotropin. Role of carbohydrate moieties in adenylate cyclase activation. J Biol Chem 257:14446-14452
39. Manjunath P, Sairam MR 1982 Biochemical, biological, and immunological properties of chemically deglycosylated human choriogonadotropin. J Biol Chem 257:7109-7115
40. Manjunath P, Sairam MR, Sairam J 1982 Studies on pituitary follitropin. X. Biochemical, receptor binding and immunological properties of deglycosylated ovine hormone. Mol Cell Endocrinol 28:125-138
41. SairamMR1982 Effects of carbohydrate removal on the structure and activity of bovine lutropin. Biochim Biophys Acta 717:149-153
42. Sairam MR, Manjunath P 1982 Studies on pituitary follitropin. XI. Induction of hormonal antagonistic activity by chemical deglycosylation. Mol Cell Endocrinol 28:139-150
43. Sairam MR 1980 Deglycosylation of ovine pituitary lutropin subunits: effects on subunit interaction and hormone activity. Arch Biochem Biophys 204:199-206
44. Keutmann HT, McIlroy PJ, Bergert ER, Ryan RJ 1983 Chemically deglycosylated human chorionic gonadotropin subunits: characterization and biological properties. Biochemistry 22:3067-3072
45. Sairam MR, Manjunath P 1983 Hormonal antagonistic properties of chemically deglycosylated human choriogonadotropin. J Biol Chem 258:445-449
46. Calvo FO, Keutmann HT, Bergert ER, Ryan RJ 1986 Deglycosylated human follitropin: characterization and effects on adenosine cyclic 3′,5′-phosphate production in porcine granulosa cells. Biochemistry 25:3938-3943
47. Aggarwal BB, Lictt P, Papkoff H, Bona-Gallo A 1980 Interaction of equine luteinizing hormone with binding sites for follicle-stimulating hormone in the rat seminiferous tubule. Endocrinology 107: 725-731
48. DiPilato LM, Cheng X, Zhang J 2004 Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci USA 101:16513-16518
49. 125I-labelled human FSH to granulosa cells from Booroola ewes which were homozygous, heterozygous or non-carriers of a major gene(s) influencing their ovulation rate. J Reprod Fertil 86:27-38
50. Zhang J, Ma Y, Taylor SS, Tsien RY 2001 Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc Natl Acad Sci USA 98:14997-15002
51. Lécureuil C, Tesseraud S, Kara E, Martinat N, Sow A, Fontaine I, Gauthier C, Reiter E, Guillou F, Crépieux P 2005 Follicle-stimulating hormone activates p70 ribosomal protein S6 kinase by protein kinase A-mediated dephosphorylation of Thr 421/Ser 424 in primary Sertoli cells. Mol Endocrinol 19:1812-1820
52. Crépieux P, Marion S, Martinat N, Fafeur V, Vern YL, Kerboeuf D, Guillou F, Reiter E 2001 The ERK-dependent signalling is stagespecifically modulated by FSH, during primary Sertoli cell maturation. Oncogene 20:4696-4709
53. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, Taunton J, Sonenberg N, Blenis J 2007 RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282:14056-14064
54. Ulloa-Aguirre A, Midgley Jr AR, Beitins IZ, Padmanabhan V 1995 Follicle-stimulating isohormones: characterization and physiological relevance. Endocr Rev 16:765-787
55. Chappel SC, Coutifaris C, Jacobs SJ 1982 Studies on the microheterogeneity of follicle-stimulating hormone present within the anterior pituitary gland of ovariectomized hamsters. Endocrinology 110:847-854
56. Ulloa-Aguirre A, Espinoza R, Damian-Matsumura P, Larrea F, Flores A, Morales L, Dominguez R 1988 Studies on the microheterogeneity of anterior pituitary follicle-stimulating hormone in the female rat. Isoelectric focusing pattern throughout the estrous cycle. Biol Reprod 38:70-78
57. Ulloa-Aguirre A, Damián-Matsumura P, Espinoza R, Dominguez R, Morales L, Flores A 1990 Effects of neonatal androgenization on the chromatofocusing pattern of anterior pituitary FSH in the female rat. J Endocrinol 126:323-332
58. Arey BJ, Stevis PE, Deecher DC, Shen ES, Frail DE, Negro-Vilar A, Lopez FJ 1997 Induction of promiscuous G protein coupling of the follicle-stimulating hormone (FSH) receptor: a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol Endocrinol 11:517-526
59. Arey BJ, Yanofsky SD, Claudia Perez M, Holmes CP, Wrobel J, Gopalsamy A, Stevis PE, Lopez FJ, Winneker RC 2008 Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochem Biophys Res Commun 368:723-728
60. Pierce KL, Premont RT, Lefkowitz RJ 2002 Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639-650
61. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, Lefkowitz RJ 2005 Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci USA 102:1442-1447
62. Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB 1997 μ-Opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272:28869-28874
63. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M 1996 Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024
64. Maudsley S, Gent JP, Findlay JB, DonnellyD1998 The relationship between the agonist-induced activation and desensitization of the human tachykinin NK2 receptor expressed in Xenopus oocytes. Br J Pharmacol 124:675-684
65. 2C receptor system: effector pathway and agonist dependence. J Pharmacol Exp Ther 302:957-962
66. Rajagopal K, Whalen EJ, Violin JD, Stiber JA, Rosenberg PB, Premont RT, Coffman TM, Rockman HA, Lefkowitz RJ 2006 β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc Natl Acad Sci USA 103:16284-16289
67. Zhai P, Yamamoto M, Galeotti J, Liu J, Masurekar M, Thaisz J, Irie K, Holle E, Yu X, Kupershmidt S, Roden DM, Wagner T, Yatani A, Vatner DE, Vatner SF, Sadoshima J 2005 Cardiac-specific overexpression of AT1 receptor mutant lacking Gαq/Gαi coupling causes hypertrophy and bradycardia in transgenic mice. J Clin Invest 115: 3045-3056
68. Xiao K, McClatchy DB, Shukla AK, Zhao Y, Chen M, Shenoy SK, Yates 3rd JR, Lefkowitz RJ 2007 Functional specialization of β-arrestin interactions revealed by proteomic analysis. Proc Natl Acad Sci USA 104:12011-12016
69. Musnier A, Heitzler D, Boulo T, Tesseraud S, Durand G, Lécureuil C, Guillou H, Poupon A, Reiter E, Crépieux P 2009 Developmental regulation of p70 S6 kinase by a G protein-coupled receptor dynamically modelized in primary cells. Cell Mol Life Sci 66:3487-3503
70. DeWire SM, Kim J, Whalen EJ, Ahn S, Chen M, Lefkowitz RJ 2008 β-Arrestin-mediated signaling regulates protein synthesis. J Biol Chem 283:10611-10620
71. Walters RW, Shukla AK, Kovacs JJ, Violin JD, DeWire SM, Lam CM, Chen JR, Muehlbauer MJ, Whalen EJ, Lefkowitz RJ 2009 β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice. J Clin Invest 119:1312-1321
72. Butnev VY, Gotschall RR, Baker VL, Moore WT, Bousfield GR 1996 Negative influence of O-linked oligosaccharides of high molecular weight equine chorionic gonadotropin on its luteinizing hormone and follicle-stimulating hormone receptor-binding activities. Endocrinology 137:2530-2542
73. Moore Jr WT, WardDN1980 Pregnant mare serum gonadotropin. Rapid chromatographic procedures for the purification of intact hormone and isolation of subunits. J Biol Chem 255:6923-6929
74. Bousfield GR, Ward DN 1984 Purification of lutropin and follitropin in high yield from horse pituitary glands. J Biol Chem 259: 1911-1921
75. Gotschall RR, Bousfield GR 1996 Oligosaccharide mapping reveals hormone-specific glycosylation patterns on equine gonadotropin α-subunit Asn56. Endocrinology 137:2543-2557
76. Bousfield GR, Liu WK, Ward DN 1989 Effects of removal of carboxy-terminal extension from equine luteinizing hormone (LH) β-subunit on LH and follicle-stimulating hormone receptor-binding activities and LH steroidogenic activity in rat testicular Leydig cells. Endocrinology 124:379-387
77. Xing Y, MoyleWR2003 Efficient preparation of glycoprotein hormones lacking an α-subunit oligosaccharide. Biochem Biophys Res Commun 303:201-205
78. Reiter E, Marion S, Robert F, Troispoux C, Boulay F, Guillou F, Crepieux P 2001 Kinase-inactive G-protein-coupled receptor kinases are able to attenuate follicle-stimulating hormone-induced signaling. Biochem Biophys Res Commun 282:71-78
79. Chopineau M, Maurel MC, Combarnous Y, Durand P 1993 Topography of equine chorionic gonadotropin epitopes relative to the luteinizing hormone and follicle-stimulating hormone receptor interaction sites. Mol Cell Endocrinol 92:229-239
80. Barthet G, Gaven F, Framery B, Shinjo K, Nakamura T, Claeysen S, Bockaert J, Dumuis A 2005 Uncoupling and endocytosis of 5-hydroxytryptamine 4 receptors. Distinct molecular events with different GRK2 requirements. J Biol Chem 280:27924 -27934
81. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ 2001 Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds. Proc Natl Acad Sci USA 98:2449-2454